Patient Heterogeneity
Cross-source consensus on Patient Heterogeneity from 1 sources and 3 claims.
1 sources · 3 claims
How it works
Evidence quality
Highlighted claims
- Long COVID research is complicated because patients may have different combinations of underlying drivers. — Long COVID: What the Research Shows and How to Recover
- A treatment may look weak in aggregate trials if only a subset of patients responds strongly. — Long COVID: What the Research Shows and How to Recover
- Identifying responsive subgroups remains an unsolved challenge in the field. — Long COVID: What the Research Shows and How to Recover